Press Releases
January 10, 2017
Debiopharm International SA Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients
October 25, 2016
Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450
April 23, 2015
Debiopharm International SA initiates clinical phase II study evaluating Debio 1450 in Staphylococcal skin infections